Filter
12934
Text search:
Treatment
Featured
Recommendations
1095
New Publications
3104
Language
Document type
No document type
6992
Studies & Reports
1978
Guidelines
1666
Manuals
623
Fact sheets
483
Strategic & Response Plan
398
Training Material
243
Situation Updates
177
Resource Platforms
115
Infographics
96
Brochures
65
Videos
42
Online Courses
39
Dashboards/Maps
8
App
3
Countries / Regions
Global
620
India
580
Kenya
328
South Africa
277
Sierra Leone
263
Liberia
253
Western and Central Europe
236
Ethiopia
228
Uganda
228
Nigeria
227
Nepal
211
Africa
189
Tanzania
182
Latin America and the Carribbean
180
Bangladesh
168
Malawi
165
Myanmar / Burma
164
Zambia
161
Rwanda
154
Syria
138
Ukraine
135
Ghana
134
Namibia
132
Congo, Democratic Republic of
125
Indonesia
102
Eastern Europe
97
Philippines
94
Russia
91
Germany
89
Zimbabwe
88
South Sudan
86
Mozambique
85
Guinea
84
Senegal
81
Lesotho
78
Brazil
77
Yemen
71
Haiti
70
South–East Asia Region
67
Cambodia
66
West and Central Africa
65
Asia
62
Burkina Faso
61
East and Southern Africa
60
Venezuela
59
Middle East and North Africa
53
Botswana
52
Colombia
45
Cameroon
42
Eswatini/ Swaziland
40
Eastern Europe and Central Asia
36
Paraguay
36
Madagascar
32
Sudan
30
Pakistan
29
Benin
29
Mali
28
Afghanistan
27
Argentina
25
Lebanon
24
Central African Republic
23
Vietnam
23
USA
22
Thailand
21
Somalia
20
Jordan
20
Peru
20
China
19
Angola
18
Western Pacific Region
18
Côte d’Ivoire / Ivory Coast
17
Iraq
17
Bolivia
17
Tajikistan
17
Ecuador
16
Chile
16
Albania
16
North America
16
Moldova
15
Guinea-Bissau
13
Sri Lanka
13
Georgia
13
Papua New Guinea
12
Laos
12
Niger
11
Spain
11
Togo
10
Turkey
10
Iran
10
Chad
9
North Macedonia
9
Burundi
9
Armenia
9
Southern Africa
9
Mexico
8
Palestine
8
Romania
8
United Kingdom
8
Malaysia
7
El Salvador
7
Greece
7
Libya
7
Bhutan
7
Poland
7
Estonia
7
Kyrgyzstan
7
Saudi Arabia
6
Egypt
6
Gambia
6
Hungary
6
Timor Leste/ East Timor
6
Morocco
5
Serbia
5
Canada
5
Uzbekistan
5
Kazakhstan
5
Jamaica
5
Belarus
5
Switzerland
4
Fiji
4
Italy
4
Japan
4
Portugal
4
Singapore
3
Honduras
3
Nicaragua
3
Djibouti
3
Mongolia
3
Turkmenistan
3
France
3
Mauritius
3
Azerbaijan
3
Guyana
3
Mauritania
2
Dominican Republic
2
Croatia
2
Guatemala
2
Other region
2
North Korea
2
Qatar
2
Bulgaria
2
Lithuania
2
Slovakia
2
Gabon
2
Tunisia
2
Ireland
1
Vanuatu
1
Austria
1
Bahamas
1
Solomon Islands
1
Australia
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
4667
Clinical Guidelines
990
Public Health
663
Women & Child Health
591
Key Resources
546
Capacity Building
304
Pharmacy & Technologies
109
Annual Report MEDBOX
3
Toolboxes
HIV
1171
Mental Health
1126
COVID-19
1014
TB
866
NTDs
549
Ebola & Marburg
480
NCDs
400
AMR
360
Disability
339
Caregiver
334
Conflict
298
Refugee
267
Malaria
249
Planetary Health
231
Pharmacy
221
Rapid Response
198
Cholera
155
Natural Hazards
132
Global Health Education
130
Health Financing Toolbox
120
2.0 Rapid Response
93
Zika
85
Specific Hazards
79
Social Ethics
52
Polio
42
Typhoon
6
South Sudan
2
Lancet 2018; 391: 700–08
Estas directrices sustituyen a los anteriores documentos de política de la OMS sobre el manejo de la ILTB en las personas con la infección por el VIH, los contactos del hogar de personas con TB y otros grupos de riesgo. Las Directrices unificadas de la OMS sobre la tuberculosis: Tratamiento preven
...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-
...
Mensagens para Comunicação dos Riscos e Envolvimento da Comunidade
The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine developers and making use of real-world data to monitor the safety and effectiveness of medicines use
...
Manuel pour les soins et la prise en charge des patients dans les centres de soins communautaires
recommended
Guide d’urgence provisoire
Manuel de Référence Mali
Latest update: 29 De 2021. Slideset updated regularly to include the latest data and guidance on non-therapeutic and therapeutic treatments for COVID-19, including authorized and investigational agents.
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Molnupiravir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Where Women have no Doctor. You can download chapter by chapter
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though TB-focused in name, it offers integration-oriented assessment,
...
Nirmatrelvir-ritonavir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Communication sur les risques et participation Communautaire
Administration of Remdesivir for COVID-19
recommended
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Este manual operativo determina los aspectos y las etapas primordiales de la ampliación programática del tratamiento preventivo de la tuberculosis, y proporciona herramientas de ejecución e instrumentos de trabajo para la adaptación al contexto local, así como indicadores de seguimiento y evalu
...